Related by context. All words. (Click for frequent words.) 76 confidence intervals CIs 75 confidence interval #.#-#.# 74 odds ratios ORs 72 hip BMD 71 univariate analyzes 71 CVD mortality 70 colorectal adenoma 70 CI #.#-#.# [002] 70 HOMA IR 70 intact parathyroid hormone 69 multivariate Cox 69 hormone receptor negative 69 advanced adenoma 69 % Confidence Interval 69 confidence interval CI 69 P ≤ 69 Univariate analysis 68 nonvertebral fracture 68 nondiabetic patients 68 % CI #.#-#.# [006] 68 CI -#.# 68 regression coefficient 68 mL/min/#.# m 2 68 logistic regression analysis 68 LV dysfunction 68 lowest tertile 68 p = .# [002] 68 multivariate adjustment 68 logistic regression model 68 serum estradiol 68 % CI #.#-#.# [007] 68 TT genotype 68 % CI #.#-#.# [008] 67 % CI #.#-#.# [001] 67 MetS 67 HER2 expression 67 multiple logistic regression 67 preoperative PSA 67 highest tertile 67 neurodevelopmental impairment 67 multivariable analysis 67 ALT elevation 67 nonobese 67 autonomic dysfunction 67 endometrial thickness 67 HbA 1c levels 67 adenoma recurrence 67 multivariate analyzes 67 thyrotropin levels 67 CC genotype 66 CI #.#-#.# [001] 66 femoral neck BMD 66 MMSE score 66 Heritability 66 HbA1C levels 66 pT3 66 CYP#D# inhibitor 66 univariate 66 univariate analysis 66 % CI #.#-#.# [003] 66 lumbar spine BMD 66 parous women 66 MDRD 66 perimenopausal women 66 allele frequencies 66 mammographic density 66 noncardiac 66 NNT = 66 ASCUS 66 nonsignificant difference 66 advanced neoplasia 66 histological subtype 66 pretest probability 66 albumin excretion 66 polyp recurrence 66 morphometric vertebral fractures 66 SUVmax 66 tertile 66 β = 66 echocardiographic parameters 66 extracapsular extension 66 mIU ml 66 conditional logistic regression 66 spirometric 66 multivariate adjusted 66 creatinine ratio 65 interobserver reliability 65 serum homocysteine 65 nonfasting triglyceride levels 65 elevated hsCRP 65 familial aggregation 65 mIU L 65 postintervention 65 intima media thickness 65 IPAH 65 haematologic 65 histologic subtype 65 recurrent venous thromboembolism 65 albumin excretion rate 65 BMI z 65 CHD mortality 65 adiponectin concentrations 65 multivariate logistic regression 65 BRCA2 mutation carriers 65 neutrophil counts 65 nmol l 65 % CI #.#-#.# [004] 65 Hb A1C 65 BRCA1 mutation carriers 65 carotid IMT 65 #Gy 65 arterial oxygen saturation 65 carotid artery intima media 65 WOMAC pain 65 Logistic regression 65 CHADS2 65 seropositivity 65 PSADT 65 highest quintile 65 Subgroup analyzes 65 subclinical atherosclerosis 65 multivariable Cox 65 euthyroid 65 invasive lobular 65 urolithiasis 65 carotid stenosis 65 perioperative mortality 65 #OHD 65 serum creatinine levels 65 LV ejection fraction 65 PSA nadir 64 baseline LDH 64 spine BMD 64 tertiles 64 biochemical recurrence 64 serum GGT 64 interobserver 64 Heavy menstrual bleeding 64 arterial thromboembolic events 64 tHcy 64 elevated LDH 64 plasma homocysteine 64 neoplasias 64 retrospective cohort 64 transferrin saturation 64 P = .# 64 Ishak fibrosis score 64 nonvertebral fractures 64 baseline serum creatinine 64 oral hypoglycemic agents 64 p = #.# [003] 64 nondiabetics 64 Poisson regression 64 multiple linear regression 64 Complication rates 64 Preoperatively 64 alanine aminotransferase ALT 64 serum lipid levels 64 sociodemographic characteristics 64 lactate dehydrogenase 64 hydroxyvitamin D levels 64 biochemical relapse 64 rho = 64 nonpregnant women 64 latent celiac disease 64 bivariate analyzes 64 neurocognitive function 64 μmol L 64 atypical hyperplasia 64 covariate 64 Multivariate logistic regression 64 ejection fractions 64 heterozygotes 64 attain statistical significance 64 mmHg diastolic 64 CP CPPS 64 carotid plaque 64 gastric cardia 64 serum IGF 64 fractional anisotropy 64 triacylglycerol concentrations 64 symptomatic VTE 64 acute cholecystitis 64 alanine aminotransferase 64 prostate carcinoma 64 Papillary 63 subclinical hyperthyroidism 63 pT2 63 nondiabetic 63 postoperative mortality 63 postoperative AF 63 tumor histology 63 serum urate levels 63 pCR 63 venous thromboembolic disease 63 fasting insulin 63 coronary calcification 63 postoperative complication 63 nmol L. 63 endometrial carcinoma 63 KRAS mutations occur 63 nonfatal MI 63 clinicopathological 63 multivariable analyzes 63 NIH CPSI 63 oxycodone CR 63 cranial irradiation 63 underwent radical prostatectomy 63 CIN3 63 clinico pathological 63 postoperative pulmonary 63 cytologic 63 myocardial viability 63 HIV HCV coinfected 63 elevated triglyceride levels 63 baseline HbA1c 63 colorectal neoplasia 63 p ≤ 63 μg L 63 severe periodontitis 63 urodynamic parameters 63 Fasting plasma glucose 63 serum magnesium 63 plasma folate 63 urine albumin 63 comorbid illnesses 63 histologically confirmed 63 FDG uptake 63 sociodemographic factors 63 β blockers 63 NMIBC 63 affective psychosis 63 % CI #.#-#.# [005] 63 CI = 63 biopsy Gleason 63 Subclinical 63 diabetes mellitus DM 63 atheroma volume 63 Breslow thickness 63 Symptom severity 63 patients undergoing CABG 63 leukocyte count 63 isoprostane 63 cerebral oxygenation 63 malignant neoplasm 63 -#.# ± [002] 63 BRCA2 carriers 63 Ejection Fraction 63 incomplete revascularization 63 undergone radical prostatectomy 63 ß = 63 μg liter 63 Stent thrombosis 63 androgen suppression 63 advanced adenomas 63 underwent CABG 63 adenoma detection 63 bioavailable testosterone 63 #.#ng/ml 63 p = NS 63 serum selenium 63 intraobserver 63 QTcF 63 neurologic complications 63 overt hypothyroidism 63 mm Hg diastolic 63 monoclonal gammopathy 62 Kaplan Meier survival 62 normotensive 62 serum parathyroid hormone 62 NHANES III 62 stratifying patients 62 pg ml 62 serum phosphate 62 underwent coronary angiography 62 nulliparous women 62 obstructive coronary 62 inversely associated 62 baseline FEV 62 statistically significant p = 62 Subgroup analysis 62 lobular breast cancer 62 preintervention 62 plasma adiponectin 62 thyroid carcinoma 62 generalized estimating 62 Multivariate analyzes 62 periprocedural 62 μg d 62 = #.#-#.# 62 hyperhomocysteinemia 62 collagenous colitis 62 serum aminotransferase levels 62 SGPT 62 HbA 1c 62 abdominal circumference 62 shorter telomere length 62 APOE genotype 62 thromboembolic 62 Cystatin C 62 -#.# mg dL [001] 62 endometrial hyperplasia 62 lymph node metastasis 62 bivariate 62 comorbid anxiety 62 grade squamous intraepithelial 62 LDL particle 62 lymph node involvement 62 troponin T 62 glycosylated hemoglobin HbA1c 62 hepatocellular carcinomas 62 logistic regression models 62 Legg Calvé Perthes disease 62 receiving ISENTRESS 62 F FDG PET 62 Comorbidities 62 nonmetastatic 62 MMSE scores 62 osteopenic 62 nonobese patients 62 mild renal insufficiency 62 interobserver agreement 62 tibiofemoral 62 PLX STROKE targeting 62 leukocyte counts 62 nonobstructive 62 Flu Cy 62 nondepressed 62 serum PTH 62 deep venous thromboses 62 cerebral infarction 62 rs# [004] 62 glomerular filtration rate 62 inflammatory biomarkers 62 coronary stenosis 62 estimated GFR 62 adnexal mass 62 abdominal adiposity 62 squamous histology 62 pmol L 62 VLBW 62 SLNB 62 SCr 62 seminal vesicle invasion 62 Lumbar spine 62 umol L 62 nontraumatic 62 carotid plaques 62 treat NNT 62 serum BDNF 62 antiphospholipid antibodies 62 relapsed MM 62 primary aldosteronism 62 dalteparin 62 Arch Intern Med 62 #.#mmol L [002] 62 Univariate 62 #.#/#.# mmHg [001] 62 statistical significance p 62 folate concentrations 62 mg BID dose 62 intravesical therapy 62 Depressive symptoms 62 femoral neck fracture 62 antiretroviral naïve 62 underwent surgical resection 62 definite stent thrombosis 62 thiopurine 62 hormone receptor status 62 lumbar spine bone 62 hydroxyvitamin D concentrations 62 perioperative complications 62 obstructive CAD 62 visceral metastases 62 r2 = 62 elevated fasting glucose 62 % CI #.#-#.# [002] 62 clinicopathological features 62 prevalences 62 invasive ductal 62 nonsignificant 62 nodal metastasis 62 CTEPH 62 POAG 62 hypovitaminosis D 62 aged ≥ 62 Plasma concentrations 62 extensive metabolizers 62 proximal colon 62 distal colon cancer 62 depressive symptomatology 62 NHANES #-# 62 artery stenosis 62 Bonferroni correction 62 noncardiovascular mortality 62 covariates 62 ANCOVA 62 subtrochanteric 62 radiotherapy RT 62 noncarriers 62 GH deficiency 61 periprocedural MI 61 arterial thickening 61 progesterone receptor negative 61 atypical ductal hyperplasia 61 urothelial carcinoma 61 Hazard Ratio HR 61 PRADAXA #mg 61 HER2 amplification 61 hypercalciuria 61 Adenomas 61 MTHFD1L gene 61 Glomerular filtration rate 61 colorectal cancer incidence 61 inhospital mortality 61 rs# [001] 61 IDDM 61 Insulin sensitivity 61 postmenopausal hormone 61 comorbid depression 61 T1a 61 gestational hypertension 61 systolic diastolic 61 aminotransferases 61 plasma triglycerides 61 logistic regression analyzes 61 Histopathological 61 elevated depressive symptoms 61 Skin sterol 61 serum sodium levels 61 CIN2 + 61 scintigraphic 61 estimated glomerular filtration 61 posttransplant 61 serum urate 61 glomerular filtration 61 proportional hazards 61 lymphocyte count 61 ductal breast cancer 61 leiomyomas 61 postoperative delirium 61 polytherapy 61 premorbid 61 serum markers 61 serum ALT 61 transabdominal 61 mm Hg systolic 61 nephrolithiasis 61 Kaplan Meier 61 lobular cancer 61 carotid intima media 61 BPS IC 61 hsCRP levels 61 abnormal cytology 61 bone scintigraphy 61 GG genotype 61 serum PSA 61 extrapyramidal symptoms 61 thromboembolic complications 61 moderate renal impairment 61 Endometrial 61 #-#,# mg 61 ß blockers 61 hepatorenal syndrome 61 BMD measurements 61 generalized edema 61 AUCs 61 atorvastatin #mg 61 μg kg 61 postop 61 thrombocytopenic 61 multivariable logistic regression 61 sensitivity specificity 61 CI #.#-#.# p = 61 metaplasia 61 symptomatic intracerebral hemorrhage 61 de novo AML 61 CR nPR 61 underwent resection 61 apolipoprotein B 61 System IPSS 61 elevated IOP 61 nonischemic 61 complete cytogenetic response 61 Visual Analogue Scale VAS 61 HRQL 61 hemoglobin A1c levels 61 nicardipine 61 bronchoalveolar lavage BAL 61 anemia hemoglobin 61 SGRQ 61 meta regression 61 URTI 61 Brief Psychiatric 61 bronchoalveolar lavage 61 locoregional recurrence 61 adenomatous 61 ventilation perfusion 61 myocardial infarctions MIs 61 liver histology 61 PASI scores 61 ductal cancer 61 PHPT 61 perioperative morbidity 61 serum ferritin 61 ATV RTV 61 NYHA functional class 61 Key secondary endpoints 61 HNSCC 61 colorectal neoplasms 61 Multivariate analysis 61 homocysteine concentrations 61 NIHSS score 61 corticosteroid dose 61 Evaluable 61 dietary calcium intake 61 parasitaemia 61 glycated hemoglobin levels 61 homozygotes 61 radiographic findings 61 posttreatment 61 Prostate specific antigen 61 familial clustering 61 statistically significant predictor 61 median survivals 61 WOMAC scores 61 Serum creatinine 61 International Prognostic Scoring 61 nadroparin 61 penetrance 61 DAS# CRP 61 coinfection 61 fetal malformations 61 FluCAM arm 61 prostate cancer CaP 61 histopathologic diagnosis 61 prostate cancer PCa 61 angiographically 61 Hemoglobin A1c 61 Multivariate analysis revealed 61 ‰ ¥ 61 graft occlusion 61 MADRS score 61 isolated systolic hypertension 61 skeletal metastases 61 distal colon 61 serum albumin 61 anastomotic leak 61 nonvertebral 61 adjunctive placebo 61 aOR 61 bladder carcinoma 60 prospectively evaluated 60 APOE e4 60 serum uric acid 60 affective psychoses 60 atherothrombotic disease 60 nonproliferative 60 pre eclamptic 60 corneal curvature 60 aspartate aminotransferase AST 60 psychiatric comorbidities 60 binary restenosis 60 lymphocytosis 60 cerebrovascular accidents 60 Adjuvant chemotherapy 60 gastric carcinoma 60 microsatellite instability 60 lacunar 60 Kaplan Meier method 60 mean ± SEM 60 euthymic patients 60 HBeAg negative patients 60 PCWP 60 EQ 5D 60 mean baseline A1C 60 metabolite concentrations 60 obstructive coronary artery 60 vertebral fracture 60 recurrent DVT 60 Mantel Haenszel 60 aldosterone antagonist 60 gross hematuria 60 urinary albumin 60 dyssynchrony 60 hypogonadal 60 â ‰ ¥ 60 thickness IMT 60 lumbar disk herniation 60 ECOG PS 60 abacavir Ziagen 60 silent myocardial ischemia 60 lung resections 60 thyrotropin 60 Serum concentrations 60 chorioamnionitis 60 creatinine clearance 60 achieved statistical significance 60 anti JCV antibodies 60 mineral density 60 lignan intake 60 pulmonary dysfunction 60 abdominal irradiation 60 thromboembolism 60 ischemic cerebrovascular 60 aspirin clopidogrel 60 neuritic 60 methotrexate monotherapy 60 variant rs# 60 x ULN 60 ROC curves 60 ischemic lesions 60 poor metabolizers 60 mmol l 60 dose Iluvien 60 macroalbuminuria 60 nmol liter 60 cTnT levels 60 lactate dehydrogenase LDH 60 Histologic 60 nonmelanoma skin cancers 60 symptomatic intracranial 60 plasma homocysteine levels 60 serum concentrations 60 LVSD 60 gene polymorphism 60 serum cortisol 60 #ng/ml 60 AST ALT 60 Index CDAI 60 monozygotic twin 60 systolic blood pressures 60 aortic atherosclerosis 60 genotypic resistance 60 suboptimal adherence 60 recurrent VTE 60 Hip fracture 60 postoperative morbidity 60 total cholesterol triglycerides 60 psychiatric comorbidity 60 subscores 60 GSTT1 60 Kruskal Wallis test 60 CrCl 60 Am J Cardiol 60 lipid elevations 60 left ventricular diastolic 60 elevated ALT 60 unresectable HCC 60 systolic BP 60 invasive carcinomas 60 atherosclerotic renal artery stenosis 60 T2 lesion volume 60 severe exacerbations 60 HGPIN 60 pancreatic prostate 60 total thyroidectomy 60 ARB telmisartan 60 elevated uric acid 60 nonparametric 60 hypophosphatemia 60 urinary calcium 60 loop diuretics 60 mmHg p = 60 postinjury 60 ABCB1 60 Kaplan Meier analysis 60 hemoglobin concentrations 60 TEAEs 60 Hyperlipidemia 60 hematopoietic cancers 60 recurrent UTI 60 CYP#D# genotype 60 serum TSH 60 Main Outcome Measure 60 serum triglycerides 60 Logistic regression analysis 60 tipranavir r 60 GBA mutations 60 corneal thickness 60 cTnI 60 Severity MSCS score 60 Proteinuria 60 noncardiovascular 60 diastolic pressures 60 Hazard Ratio = 60 LDL HDL 60 bronchial hyperresponsiveness 60 5q 60 prolonged QT interval 60 systolic dysfunction 60 Operative mortality 60 metachronous 60 pmol liter 60 corrected QT interval 60 urinary albumin excretion 60 spontaneous bacterial peritonitis 60 intima media thickness IMT 60 Retreatment 60 carotid artery thickness 60 antigen PSA levels 60 perinatal outcomes 60 hypertension diabetes mellitus 60 Kaplan Meier curves 60 REYATAZ r arm 60 interleukin IL -6 60 gadolinium enhanced 60 HRCT 60 thyroglobulin 60 postmenopausal hormones 60 HRQoL 60 pretransplant 60 MGUS 60 HRQOL 60 logistic regression 60 waist circumferences 60 undetectable PSA 60 abnormal ejaculation 60 Baseline characteristics 60 Framingham Offspring 60 fructosamine 60 Socio demographic 60 hepatic enzymes 60 Histopathologic 60 mutated K ras 60 mammographic breast density 60 vitamin D inadequacy 60 mucinous 60 Comorbidity 60 transient elastography 60 artery calcification 60 cortical atrophy 60 postoperative infections 60 overt nephropathy 60 cough dyspnea 60 DAS# scores 60 serum folate concentrations 60 FEV ^ sub 60 CORE OM 60 HER2 overexpression 60 eNO 60 cardioembolic stroke 60 p = .# [001] 59 hemodynamically significant 59 Calcium intake 59 cTnT 59 nmol L 59 Viral load 59 dyslipidaemia 59 antibody titer 59 sternal wound infections 59 subscale scores 59 inhibin B 59 N telopeptide 59 chest radiographs 59 normoxic 59 PCA3 scores 59 lopinavir r arm 59 interrater reliability 59 nonfatal myocardial infarction 59 knee osteoarthritis OA 59 serum vitamin D 59 NPH insulin 59 T2DM 59 serum retinol 59 esophageal carcinoma 59 PaO 2 59 tibolone 59 carotid atherosclerosis 59 glycemic variability 59 ADCS CGIC 59 nonmelanoma 59 symptom exacerbation 59 -#.# log# 59 rebleeding 59 CSF biomarkers 59 nonfatal stroke 59 HIV uninfected 59 Hb A1c 59 distal radial fractures 59 Randomized trials 59 AUC0 59 hippocampal volume 59 adjuvant radiotherapy 59 node metastases 59 papillary renal cell carcinoma 59 FOLFIRI alone 59 Kaplan Meier estimates 59 Thromboembolic 59 limiting generalizability 59 prospectively defined 59 nmol 59 HOXB# 59 hours postdose 59 preoperative chemotherapy 59 Thal Dex 59 sitosterol 59 Charlson comorbidity index 59 hematological parameters 59 serum lipid 59 extracolonic findings 59 umbilical artery 59 hepatic fat 59 carotid bruit 59 ratio WHR 59 testicular germ cell 59 bivalirudin monotherapy 59 T2D 59 abnormal glucose tolerance 59 Main Outcome Measures 59 lower extremity amputation 59 transvaginal sonography 59 asymptomatic PAD 59 beta carotene supplementation 59 revascularizations 59 plasma leptin 59 log# copies mL 59 bivariate analysis 59 urinary N telopeptide 59 baseline A1C 59 plasma cortisol 59 cardiac malformations 59 nonfasting triglycerides 59 BRCA1 mutations 59 N Engl J 59 ovarian malignancy 59 interquartile range 59 renal cysts 59 chi squared 59 #F FDG PET 59 affective disorders 59 nonfatal myocardial infarction MI 59 hepatocellular carcinoma liver 59 BRCA mutation carriers 59 atrophic gastritis 59 dysglycemia 59 obese postmenopausal 59 serum triglyceride 59 Rating Scale BPRS 59 conjugated equine estrogen 59 prolactin elevation 59 clinically insignificant 59 PCa 59 paricalcitol 59 nonexposed 59 Invasive Breast Cancer 59 Asymptomatic 59 dapagliflozin plus 59 differential gene expression 59 oxidative stress markers 59 histologic findings 59 BENICAR HCT 59 subsyndromal 59 K ras mutations 59 breast endometrial 59 creatine kinase MB 59 FeNO 59 stepwise logistic regression 59 Basal Cell 59 elevated creatinine 59 #.#mmHg 59 cGy 59 Suicidal ideation 59 deletion 5q 59 COHb 59 left ventricular systolic 59 fasting plasma 59 Radical prostatectomy 59 osteosarcomas 59 dehydroepiandrosterone sulfate 59 aspartate aminotransferase 59 risk reducing salpingo 59 IOP lowering 59 FDA defined valvulopathy 59 clinically localized prostate 59 triglyceride concentrations 59 hMG 59 ezetimibe simvastatin 59 serum testosterone 59 postprocedure 59 fibroids endometriosis 59 operable breast cancer 59 maternal serum 59 #mmHg [001] 59 Supplementary Table 59 Adverse effects 59 symptomatic intracranial hemorrhage 59 white matter hyperintensities 59 DEXA scans 59 mineral density BMD 59 liver metastasis 59 allergic eczema 59 RNFL thickness 59 perioperatively 59 abnormal lipid levels 59 prognostic variables 59 axial length 59 specific antigen PSA 59 Atherosclerotic 59 intraclass correlation coefficient 59 deCODE BreastCancer TM 59 HDL cholesterol triglycerides 59 mammographically 59 transaminase elevations 59 cytogenic 59 carotid artery blockage 59 Secondary efficacy endpoints 59 D dimer 59 pulmonary capillary wedge 59 anthropometric measures 59 NNRTI resistance 59 nonalcoholic steatohepatitis 59 Ischemic heart 59 abnormal lipid 59 Fasting glucose 59 #OHD levels 59 IQR 59 ELBW infants 59 ertapenem 59 concomitant medications 59 diastolic blood pressures 59 colonic polyps 59 aortic stiffness 59 PANSS scores 59 cerebral microbleeds 59 Multivariate analysis showed 59 elevated CRP 59 prognostic indicators 59 waist circumference WC 59 protein excretion 59 nitrotyrosine 59 #mg/dL [001] 59 Hazard Ratio 59 serum CRP 59 -#.# log# copies mL 59 variance ANOVA 59 multivariate regression 59 nonfasting 59 undetectable HBV DNA 59 death reinfarction 59 CHD CVD 59 Multiple logistic regression 59 Hcy 59 tHcy concentrations 59 visceral adiposity 59 VLDL cholesterol 59 hypercoagulable 59 Folfox 59 Preoperative 59 QIDS SR 59 Elevated serum 59 confirmed thrombotic cardiovascular 59 anogenital distance 59 mmHg systolic 59 TURBT 59 correlation coefficients 59 atherogenic dyslipidemia 59 glycated hemoglobin HbA1c 59 hormone therapy estrogen 59 rosuvastatin #mg 59 serum bilirubin 59 preeclamptic 59 surgically induced 59 Crohn Disease Activity 59 autoimmune thyroid 59 methacholine challenge 59 ANOVA 59 gene APOE 58 arterial thromboembolism 58 mL/min/#.# m2 58 interquartile range IQR 58 radical prostatectomy RP 58 completely resected 58 Endothelial function 58 atherothrombotic 58 plain radiographs 58 Leydig cell 58 plasma creatinine 58 ± SD 58 labetalol 58 leukopenia 58 tryptase 58 HF hospitalization 58 XIENCE V demonstrated 58 oesophageal adenocarcinoma 58 NIHSS 58 carotid artery stenting CAS 58 AOR = 58 MLH1 58 idiopathic PAH 58 gallstone disease 58 LUTS 58 Chemotherapy induced 58 #.#-#.# p = 58 anemia neutropenia 58 smoldering myeloma 58 thyroid hormone levels 58 reoperations 58 bronchoalveolar